Lung Cancer Screening Does Not Increase Unnecessary Surgery Rates
the ONA take:
Lung cancer screening programs result in a low incidence of surgical intervention for non-lung cancer diagnoses and a rare incidence of surgical intervention for benign disease, a new study published in the journal The Annals of Thoracic Surgery has shown.
For the study, researchers at Lahey Hospital & Medical Center retrospectively analyzed the surgical outcomes of 25 of the 1,654 patients who underwent low-dose computer tomography lung cancer screening.
Results showed that of the 25 that underwent surgery, five had non-lung cancer diagnoses, equating to an incidence of surgery for non-lung cancer diagnosis of 0.30%.
Researchers found that the incidence of surgery for benign disease was 0.24%. The other 20 patients had lung cancer, of which 18 had early stage disease and two had late stage disease.
“Lung cancer screening saves lives, and our study serves as a model for how to set up a screening program that is safe and effective for patients,” said Christina Williamson, MD, from Lahey Hospital & Medical Center.
“It is only by minimizing the number of operations for benign disease and maintaining a low morbidity and mortality for surgical resection that the full benefit of lung cancer screening can be realized in its widespread adoption in clinical practice,” Williamson said.
Lung cancer screening programs result in a low incidence of surgical intervention for non-lung cancer diagnoses.
- Prehabilitation Program Improves Preoperative Fitness in Patients With Colorectal Cancer
- Acupuncture Improves Postoperative Symptoms in Women Undergoing Surgery for Breast Cancer
- Combination of Gemcitabine and New CHK1 Inhibitor Is Effective in Soft Tissue Sarcomas
- Alcohol Consumption, Particularly White Wine, Associated With Increased Risk of Melanoma
- In HER2+ Breast Cancer, Higher TIL Levels Associated With Improved OS
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Timing Chemotherapy Administration to Circadian Rhythm Improves Drug Effectiveness
- New Therapy Blocks Breast Cancer Cells From Entering and Hiding in Bone Marrow to Form Latent Metastases
- Costs, Complications Higher for Women Who Undergo Second Surgery After BCS
- Omitting RT in Certain Older Women With Early Breast Cancer is Safe
- Fluorescent Nanoparticles Represent Novel Detection Method of HER2 Expression
- Assessment of Stromal Features in DCIS Requires Robustness
- Profile of Tivantinib and its Potential in the Treatment of Hepatocellular Carcinoma: the evidence to date
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|